These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35883253)

  • 1. Prognostic value of various markers in recovery from peripartum cardiomyopathy: a systematic review and meta-analysis.
    Hosseinpour A; Hosseinpour H; Kheshti F; Abdollahifard S; Attar A
    ESC Heart Fail; 2022 Oct; 9(5):3483-3495. PubMed ID: 35883253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping.
    Liang YD; Xu YW; Li WH; Wan K; Sun JY; Lin JY; Zhang Q; Zhou XY; Chen YC
    J Cardiovasc Magn Reson; 2020 Jan; 22(1):2. PubMed ID: 31902370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting poor left ventricular function recovery in Peripartum cardiomyopathy.
    Prameswari HS; Iswandi CP; Hasan M; Martanto E; Putra ICS; Kamarullah W; Dewi TI; Akbar MR
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2279018. PubMed ID: 37935592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of NT-proBNP for myocardial recovery in peripartum cardiomyopathy (PPCM).
    Hoevelmann J; Muller E; Azibani F; Kraus S; Cirota J; Briton O; Ntsekhe M; Ntusi NAB; Sliwa K; Viljoen CA
    Clin Res Cardiol; 2021 Aug; 110(8):1259-1269. PubMed ID: 33555408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel marker of persistent left ventricular systolic dysfunction in patients with peripartum cardiomyopathy: monocyte count- to- HDL cholesterol ratio.
    Ekizler FA; Cay S
    BMC Cardiovasc Disord; 2019 May; 19(1):114. PubMed ID: 31092205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel score to predict left ventricular recovery in peripartum cardiomyopathy derived from the ESC EORP Peripartum Cardiomyopathy Registry.
    Jackson AM; Goland S; Farhan HA; Yaseen IF; Prameswari HS; Böhm M; Jhund PS; Maggioni AP; van der Meer P; Sliwa K; Bauersachs J; Petrie MC
    Eur Heart J; 2024 Apr; 45(16):1430-1439. PubMed ID: 38282532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripartum cardiomyopathy in Iraq: initial registry-based data and 6 month outcomes.
    Farhan HA; Yaseen IF
    ESC Heart Fail; 2021 Oct; 8(5):4048-4054. PubMed ID: 34184413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of Early Diagnosis in Peripartum Cardiomyopathy.
    Lewey J; Levine LD; Elovitz MA; Irizarry OC; Arany Z
    Hypertension; 2020 Jan; 75(1):91-97. PubMed ID: 31707840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics and Long-term Predictors of Persistent Left Ventricular Systolic Dysfunction in Peripartum Cardiomyopathy.
    Li W; Li H; Long Y
    Can J Cardiol; 2016 Mar; 32(3):362-8. PubMed ID: 26586094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new risk score for the assessment of outcomes for Chinese patients with peripartum cardiomyopathy.
    Zhang Z; Zheng W; Chen M; Xie Q; Huang M; Li W; Huang Z
    Heart Lung; 2023; 60():81-86. PubMed ID: 36933287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of the neutrophil-to-lymphocyte ratio in predicting left ventricular recovery in patients with peripartum cardiomyopathy.
    Gürkan U; Akgöz H; Aksoy Ş; Can Gürkan Ö; Osken A; Unal Dayi S; Oz D; Haci R
    Wien Klin Wochenschr; 2017 Dec; 129(23-24):893-899. PubMed ID: 28702739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry.
    Jackson AM; Petrie MC; Frogoudaki A; Laroche C; Gustafsson F; Ibrahim B; Mebazaa A; Johnson MR; Seferovic PM; Regitz-Zagrosek V; Mbakwem A; Böhm M; Prameswari HS; Fouad DA; Goland S; Damasceno A; Karaye K; Farhan HA; Hamdan R; Maggioni AP; Sliwa K; Bauersachs J; van der Meer P;
    Eur J Heart Fail; 2021 Dec; 23(12):2058-2069. PubMed ID: 34114268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Left Ventricular Strain at Presentation Is Associated with Subsequent Recovery in Patients with Peripartum Cardiomyopathy.
    Sugahara M; Kagiyama N; Hasselberg NE; Blauwet LA; Briller J; Cooper L; Fett JD; Hsich E; Wells G; McNamara D; Gorcsan J;
    J Am Soc Echocardiogr; 2019 Dec; 32(12):1565-1573. PubMed ID: 31563436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome in German and South African peripartum cardiomyopathy cohorts associates with medical therapy and fibrosis markers.
    Azibani F; Pfeffer TJ; Ricke-Hoch M; Dowling W; Pietzsch S; Briton O; Baard J; Abou Moulig V; König T; Berliner D; Libhaber E; Schlothauer S; Anthony J; Lichtinghagen R; Bauersachs J; Sliwa K; Hilfiker-Kleiner D
    ESC Heart Fail; 2020 Apr; 7(2):512-522. PubMed ID: 32064780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of outcome in 176 South African patients with peripartum cardiomyopathy.
    Blauwet LA; Libhaber E; Forster O; Tibazarwa K; Mebazaa A; Hilfiker-Kleiner D; Sliwa K
    Heart; 2013 Mar; 99(5):308-13. PubMed ID: 23118348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NT-proBNP and predictors of event free survival and left ventricular systolic function recovery in peripartum cardiomyopathy.
    Imran TF; Mohebali D; Lopez D; Goli RR; DeFilippis EM; Truong S; Bello NA; Gaziano JM; Djousse L; Coglianese EE; Feinberg L; Wu WC; Choudhary G; Arany Z; Kociol R; Sabe MA
    Int J Cardiol; 2022 Jun; 357():48-54. PubMed ID: 35358637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of early and delayed recovery in peripartum cardiomyopathy: a prospective study of 52 Patients.
    Biteker M; Özlek B; Özlek E; Çil C; Çelik O; Doğan V; Başaran Ö
    J Matern Fetal Neonatal Med; 2020 Feb; 33(3):390-397. PubMed ID: 29945487
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term follow-up in peripartum cardiomyopathy patients with contemporary treatment: low mortality, high cardiac recovery, but significant cardiovascular co-morbidities.
    Moulig V; Pfeffer TJ; Ricke-Hoch M; Schlothauer S; Koenig T; Schwab J; Berliner D; Pfister R; Michels G; Haghikia A; Falk CS; Duncker D; Veltmann C; Hilfiker-Kleiner D; Bauersachs J
    Eur J Heart Fail; 2019 Dec; 21(12):1534-1542. PubMed ID: 31724271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of subsequent pregnancy in women with peripartum cardiomyopathy: a systematic review and meta-analysis.
    Wijayanto MA; Myrtha R; Lukas GA; Rahma AA; Hanifa SN; Zahira HA; Ilyas MF
    Open Heart; 2024 Apr; 11(1):. PubMed ID: 38569669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In peripartum cardiomyopathy plasminogen activator inhibitor-1 is a potential new biomarker with controversial roles.
    Ricke-Hoch M; Hoes MF; Pfeffer TJ; Schlothauer S; Nonhoff J; Haidari S; Bomer N; Scherr M; Stapel B; Stelling E; Kiyan Y; Falk C; Haghikia A; Binah O; Arany Z; Thum T; Bauersachs J; van der Meer P; Hilfiker-Kleiner D
    Cardiovasc Res; 2020 Sep; 116(11):1875-1886. PubMed ID: 31711127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.